Hugues Wallemacq
Directeur Général chez EXO Biologics SA
Profil
Hugues Wallemacq is currently the Chief Executive Officer at EXO Biologics SA since 2022.
He is also the Director at ImCyse SA, Osivax SAS, Antelope Dx BV, Man & Science NV, and a Board Member at Unisensor SA since 2020.
Additionally, he serves as an Investment Manager at Noshaq SA since 2020.
Previously, he worked as a Director at GlaxoSmithKline Pharmaceuticals SA (Belgium) from 2013 to 2016.
Dr. Wallemacq obtained an MBA from Maastricht University in 2020.
Postes actifs de Hugues Wallemacq
| Sociétés | Poste | Début |
|---|---|---|
Osivax SAS
 Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Directeur/Membre du Conseil | - |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Directeur/Membre du Conseil | 01/01/2020 |
Antelope Dx BV
 Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | Directeur/Membre du Conseil | - |
EXO Biologics SA
 EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Directeur Général | 01/05/2022 |
Unisensor SA
 Unisensor SA Miscellaneous Commercial ServicesCommercial Services Unisensor SA is a Belgian biotech company that specializes in improving food safety through screening solutions to detect antibiotics, mycotoxins, and other contaminants. Unisensor is based in Seraing, Belgium. The private company develops innovative, fast, and easy-to-use diagnostic tests that are now connected. The company was founded in 1997 by Benoit Granier, who has been the CEO since then. | Directeur/Membre du Conseil | 01/01/2020 |
Noshaq SA
 Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | Private Equity Investor | 01/01/2020 |
Man & Science NV
 Man & Science NV Pharmaceuticals: MajorHealth Technology Man & Science NV is a Belgian medical device company that develops a novel, minimally invasive, battery-free neurostimulation system to reduce the pain and frequency of severe headache attacks. The company is based in Mont-Saint-Guibert, Belgium, and has subsidiaries in Norway. The company's therapies allow headache patients to return to a normal, pain-free life. The company's team consists of experienced scientists, engineers, clinical research specialists, business experts, and successful start-up founders and entrepreneurs. The company was founded in 2011 by Robert Taub, and Fabian Suarez Gonzalez has been the CEO of the company since 2022. | Directeur/Membre du Conseil | - |
Anciens postes connus de Hugues Wallemacq
| Sociétés | Poste | Fin |
|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Directeur/Membre du Conseil | 01/09/2016 |
Formation de Hugues Wallemacq
| Maastricht University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Osivax SAS
Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Health Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Health Technology |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | Technology Services |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Health Technology |
Unisensor SA
Unisensor SA Miscellaneous Commercial ServicesCommercial Services Unisensor SA is a Belgian biotech company that specializes in improving food safety through screening solutions to detect antibiotics, mycotoxins, and other contaminants. Unisensor is based in Seraing, Belgium. The private company develops innovative, fast, and easy-to-use diagnostic tests that are now connected. The company was founded in 1997 by Benoit Granier, who has been the CEO since then. | Commercial Services |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | Finance |
Man & Science NV
Man & Science NV Pharmaceuticals: MajorHealth Technology Man & Science NV is a Belgian medical device company that develops a novel, minimally invasive, battery-free neurostimulation system to reduce the pain and frequency of severe headache attacks. The company is based in Mont-Saint-Guibert, Belgium, and has subsidiaries in Norway. The company's therapies allow headache patients to return to a normal, pain-free life. The company's team consists of experienced scientists, engineers, clinical research specialists, business experts, and successful start-up founders and entrepreneurs. The company was founded in 2011 by Robert Taub, and Fabian Suarez Gonzalez has been the CEO of the company since 2022. | Health Technology |
